Search for: "Medtronic Inc." Results 881 - 900 of 1,084
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Dec 2010, 5:00 am by Ali Kaiser
Nuclear Regulatory Commission, and has also served on the boards at FedEx Corporation, Marathon Oil Corporation, Medtronic, Inc., Public Service Enterprise Group Incorporated, and NYSE Euronext. [read post]
8 May 2009, 5:01 am
Medtronic, Inc., 128 S.Ct. 999 (2008), holding that the preemption clause of the Medical Device Amendments of 1976 (21 U.S.C. [read post]
3 Jun 2009, 4:39 am
Medtronic, Inc., 128 S.Ct 999, 1011 (2008). [read post]
19 Jun 2007, 9:06 am
Caterpillar, Inc., 480 F.3d 202, 209 (3d Cir. 2007); Pedraza v. [read post]
12 Jan 2007, 6:20 pm
Going back to Justice Scalia in Medtronic, the Scalia/Kennedy schism therein looks pretty tame compared to the footnote battle of Scalia/Thomas in MedImmune. [read post]
5 Aug 2009, 1:19 pm
Medtronic, Inc., 128 S.Ct. 999 (2008), which held that the PMA approval process for Class III devices imposes federal requirements that preempt state tort claims which would impose additional or different "requirements" regarding the safety and efficacy of the device, pursuant to the express preemption clause found in the Medical Devices Amendment of 1976. [read post]
8 Dec 2010, 2:20 am by Marie Louise
– Nova Biomedical fight for survival following patent threats from Abbott, Roche, Medtronic (IP Directions) Pathogens and the Nagoya Protocol of the Convention on Biological Diversity (PatentlyBIOtech) Australia: Federal Court punishes CSL for amendment delay: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (Patentology) Australia: AusBiotech, legal academics and ARDR weigh in on gene patent debate (Patentology) Australia: Gene patent amendment bill introduced (IP Whiteboard)… [read post]
10 Aug 2011, 7:46 pm by Lawrence B. Ebert
Medtronic Sofamor Danek USA, Inc., 620 F.3d 1305, 1317 (Fed. [read post]
2 Jul 2013, 8:11 am by Ben Vernia
In addition to today’s settlement, the government previously settled with Medtronic Spine LLC, the corporate successor to Kyphon Inc., for $75 million to settle allegations that the company defrauded Medicare by counseling hospital providers to perform kyphoplasty procedures as inpatient rather than outpatient procedures. [read post]